Tricanna Pre-Rolled Cannabis Products To Reach All Major Canada Markets Via HYTN
HYTN Cannabis Inc. a wholly owned subsidiary of HYTN Innovations Inc.’s (CSE:HYTN), has entered into a manufacturing agreement with Tricanna Industries Inc.
HYTN Launches Nano Gummies Offering ‘Faster And More Consistent Cannabis Experience’
HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product.
HYTN Awarded Medical Cannabis Sales Licence By Health Canada
HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes.
HYTN Grows Exports With Cannabis Flower Sales To Australia
HYTN Innovations Inc. (CSE:HYTN) has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the company’s supply agreement with TCann Pty Ltd.
HYTN’s Marijuana Products To Reach Australian Medical Cannabis Market
HYTN Innovations Inc. (CSE: HYTN) has successfully developed, exported and launched cannabis nano-emulsions featuring its’s proprietary Elevation Technology into the Australian medical cannabis market, through a manufacturing and sales agreement with Promethean BioPharma.
HYTN Innovations Receives Health Canada’s Approval To Sell Cannabis
HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.